16 Oct 2020 --- In nutrition news this week, FrieslandCampina provided Singapore parents with tracking technology that outlines its Friso infant milk supply chain journey. Meanwhile, Bayer’s investment arm invested in biotech company Azitra Inc. to develop solutions that move the paradigm from treatment to cure in dermatology. Nestlé Health Science (NHSc) completed its acquisition of Aimmune Therapeutics and OptiBiotix launched OptiBiome in Australia and New Zealand under the Optislim brand.
